The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium. Dear Friends, On 14 May, the WHO released the document “WHO guideline on balanced national controlled medicines policies to ensure medical access and safety: rapid communication” – accessible at https://iris.who.int/bitstream/handle/10665/381452/B09419-eng.pdf?sequence=1 The purpose is ‘to assist WHO Member States ...
On the 28th of April, Quamed issued two QCP certificates to Amex Healthcare. The first one is a QCP MQAS certificate: QCP-MQAS-EN-003. It was issued to AMEX Healthcare GmbH in Austria. They are located at the Heiligenstädter Straße 31/3, Vienna, 1190. The second one is a QCP GSDP certificate: QCP-GSDP-EN-009. It was issued to AMEX ...
The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium. Ref. WHO Expert Committee on Specifications for Pharmaceutical Preparations: fifty-eight report. Geneva: World Health Organization; 2025 (WHO Technical Report Series, No. 1060). Licence: CC BY-NC-SA 3.0 IGO. Dear friends, The WHO has just published the 58th report of the Expert Committee ...
Final stretch at the World Health Organisation: a historic pandemic agreement is within reach! After more than 3 years of negotiations, member states are finalising today a crucial treaty to ensure a fairer and more equitable response to future pandemics. Despite compromises, the agreement marks major progress by putting equitable access to treatments and technologies ...
The World Health Organization (WHO) has issued a Medical Product Alert for falsified OXYCONTIN 80mg (oxycodone hydrochloride) found in Switzerland. Laboratory testing revealed that the counterfeit tablets contain potent synthetic opioids, likely nitazene compounds, instead of oxycodone, posing a high risk of overdose and death. The falsified product mimics genuine MUNDIPHARMA-manufactured OXYCONTIN from Poland but features incorrect batch and ...
Quamed would like to congratulate the ARP in Senegal and the RFDA in Rwanda on this major achievement. We have seen firsthand how hard they have worked and how much they have accomplished over the past years. Another milestone achieved related to increased access to quality medicines! https://www.who.int/news/item/05-12-2024-senegal-and-rwanda-achieve-who-maturity-level-3-in-medicines-regulation
We are delighted to announce that our “Implementing the WHO GSDP and MQAS Guidelines” course has been awarded the FIP Seal. You can read about our courses on the International Pharmaceutical Federation (FIP) microsite here. The course is accessible on the QUAMED Learning Platform (learning.quamed.org). The course will expand your expertise on pharmaceutical quality assurance. ...
Quamed launched its Quality Certification Programme (QCP) in early 2023, generating significant interest across the sector. To date, 63 organizations have expressed interest in pursuing QCP certification, with 32 submitting formal applications. Eight organizations have successfully obtained QCP certificates, while six more are progressing through the certification process. These numbers reflect both strong market interest ...
The World Health Organization (WHO) has issued an urgent alert about falsified OZEMPIC (semaglutide) detected in Brazil, the UK, and the USA. These counterfeit products pose significant health risks, including ineffective treatment and potential contamination. Identified batches include LP6F832, NAR0074 with serial number 430834149057, and falsified versions of genuine batch MP5E511. The public is advised ...
We would like to congratulate the MCAZ on becoming the 6th country in Africa to achieve WHO maturity level 3. We are indirectly profiting from their expertise as our colleague Linda Mudyiwenyama was part of the MCAZ team up to two years ago. Linda is currently collaborating with the Rwanda FDA in their quest to ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.